医疗设备制造商Enovis Corporation（股票代码：ENOV）周四盘前股价大幅下挫，跌幅高达8%。这一走势主要受到公司下调2025年利润预期的影响。
根据最新公告，Enovis将2025年每股收益预期从此前的3.10美元至3.25美元区间下调至2.95美元至3.10美元区间。尽管公司同时上调了2025年的营收预期，从原先的21.9亿美元至22.2亿美元提高到22.2亿美元至22.5亿美元，但投资者似乎更关注利润预期的下调。
值得注意的是，Enovis第一季度的表现仍然亮眼。公司报告称，第一季度调整后每股收益达到0.81美元，超过分析师预期的0.74美元。然而，市场对公司未来盈利能力的担忧似乎盖过了短期业绩的利好。券商Evercore ISI指出，Enovis股价表现不佳可能与关税担忧有关。这表明，除了公司自身因素外，外部经济环境的不确定性也在影响投资者信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.